Acquirer
Cambrex
Cambrex appears as the named buyer in 3 recorded transactions between 2016 and 2018, most often in healthcare & life sciences. 2 of those were bought from a private equity seller, which makes this a buyer that funds in the sector actually exit to.
Record
What Cambrex has bought
Every recorded transaction where Cambrex is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Avista Pharma Solutions | Healthcare & Life Sciences | Ampersand Capital Partners PE | 2018-11-20 | $252m |
| Cambrex Drug Product- Business Unit | Healthcare & Life Sciences | SK Capital Partners PE | 2018-07-23 | $425m |
| PharmaCore | Healthcare & Life Sciences | — | 2016-09-26 | $25m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.